Therefore, we investigated the expression level of beta-2-microglobulin mRNA (B2M) and human leukocyte antigen (HLA) in both groups of patients and found the expression of B2M is downregulated compared to the responding tumours (Figure 2C, Supplementary Figure S2). Here, B2M is linked to neoplasm.